Cellomics Acquires UK Software Firm Momentum Healthcare | GenomeWeb

NEW YORK, July 12 - Cellomics, the Pittsburgh, PA-based maker of integrated informatics and cell-screening technologies, has acquired Momentum Healthcare, a developer of drug discovery software, the company said Thursday.

Terms of the deal, which was formalized today but has been under negotiation for some time, were not disclosed and a company official declined to comment immediately.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.